Archive - June 2019
Recent Ozempic, Victoza data ‘promising’ for diabetic kidney disease
EMA validates Santhera’s Puldysa MAA
Kymab, LifeArc form medicines discovery alliance
Daiichi Sankyo Provides Update on FDA Review of Quizartinib for the Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Correvio Resubmits Brinavess (vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation
Krystal Bio preps pivotal trials for rare skin disease gene therapy
The 2019 Sales Awards introduces a brand new category for sales managers
Liver cancer failure dents Opdivo potential by $1bn, says analyst